ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

NCI RFAs Available

May 5, 2000

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993